A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Inozyme Pharma, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 28,364 shares of INZY stock, worth $74,880. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,364
Previous 24,405 16.22%
Holding current value
$74,880
Previous $108,000 37.04%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.31 - $6.0 $17,063 - $23,754
3,959 Added 16.22%
28,364 $148,000
Q2 2024

Aug 14, 2024

BUY
$4.33 - $7.31 $105,673 - $178,400
24,405 New
24,405 $108,000

Others Institutions Holding INZY

About Inozyme Pharma, Inc.


  • Ticker INZY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,145,700
  • Market Cap $106M
  • Description
  • Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...
More about INZY
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.